Skip to content
Search

Latest Stories

Chelmsford drug dealer operating as 'unlicensed chemist' jailed for six years

Chelmsford drug dealer operating as 'unlicensed chemist' jailed for six years

Police discovered more than 50,000 pills and tablets of varying types at his residence on Wood Street in Chelmsford.

A drug dealer who was operating as an “unlicensed chemist” and selling prescription drugs online has been jailed for six years, according to Essex Police.


The convict, identified as 49-year-old Christopher Depp, aka David Jones, was supplying a range of drugs from his home to “vulnerable people” using the postal service, local police revealed on Friday (February 16).

Police conducted a search operation at his address in Wood Street, Chelmsford, in July last year and found more than 50,000 pills and tablets of varying types, stashed in toolboxes and spaces around the property.

To process the large-scale sale and shipping of controlled drugs across the UK, Depp had set up a room in his property as an office space.

He promoted the sale of medications through various social media platforms and messaging applications, and accepted payment from his large customer base using “fraudulently obtained” bank accounts.

Depp admitted offering to supply a controlled drug of Class A and being involved in the distribution of a controlled drug of Class B and a controlled drug of Class C.

He also admitted possessing identity documents with intent, an article for use in fraud, and a controlled drug of Class B.

Chelmsford Crown Court on Wednesday 14 February sentenced him to six years of prison.

Essex Police detective inspector Frazer Low described it as “an unusual case” as Depp was mainly serving customers looking to obtain prescription drugs.

“This doesn’t make the operation any less dangerous. These drugs should only have been accessible and available to those who had seen their doctor and obtained a prescription,” he said.

According to Low, Depp had “no regard” for the quantities of medication his customers consumed or “the reasons for their consumption.”

“This was not a service for those in need, it was run as a business preying upon often vulnerable people seeking medication for their illnesses, putting them at risk,” he added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less